138
Views
0
CrossRef citations to date
0
Altmetric
Original Research

Keratin 17 is Not Always a Marker of Proliferation of Keratinocytes in Skin Diseases

, , &
Pages 1247-1251 | Published online: 15 Sep 2021

References

  • Ide M, Kato T, Ogata K, Mochiki E, Kuwano H, Oyama T. Keratin 17 expression correlates with tumor progression and poor prognosis in gastric adenocarcinoma. Ann Surg Oncol. 2012;19(11):3506–3514. doi:10.1245/s10434-012-2437-9
  • Kim S, Wong P, Coulombe PA. A keratin cytoskeletal protein regulates protein synthesis and epithelial cell growth. Nature. 2006;441(7091):362–365. doi:10.1038/nature04659
  • Karantza V. Keratins in health and cancer: more than mere epithelial cell markers. Oncogene. 2011;30(2):127–138. doi:10.1038/onc.2010.456
  • Freedberg IM, Tomic-Canic M, Komine M, Blumenberg M. Keratins and the keratinocyte activation cycle. J Invest Dermatol. 2001;116(5):633–640. doi:10.1046/j.1523-1747.2001.01327.x
  • Jiang M, Sun Z, Dang E, et al. TGFbeta/SMAD/microRNA-486-3p signaling axis mediates keratin 17 expression and keratinocyte hyperproliferation in psoriasis. J Invest Dermatol. 2017;137(10):2177–2186. doi:10.1016/j.jid.2017.06.005
  • Dutz JP. T-cell-mediated injury to keratinocytes: insights from animal models of the lichenoid tissue reaction. J Invest Dermatol. 2009;129(2):309. doi:10.1038/jid.2008.242
  • Li X, Li J, Yang Y, et al. Differential gene expression in peripheral blood T cells from patients with psoriasis, lichen planus, and atopic dermatitis. J Am Acad Dermatol. 2013;69(5):e235–e243. doi:10.1016/j.jaad.2013.06.030
  • Schofield JK, De Berker D, Milligan A, et al. Keratin expression in cutaneous lichen planus. Histopathology. 1995;26(2):153–158. doi:10.1111/j.1365-2559.1995.tb00645.x
  • Pereira MP, Steinke S, Zeidler C, et al. European Academy of Dermatology and Venereology European Prurigo Project: expert consensus on the definition, classification and terminology of chronic prurigo. J Eur Acad Dermatol Venereol. 2018;32(7):1059–1065. doi:10.1111/jdv.14570
  • Lotti T, Buggiani G, Prignano F. Prurigo nodularis and lichen simplex chronicus. Dermatol Ther. 2008;21(1):42–46. doi:10.1111/j.1529-8019.2008.00168.x
  • Ständer S, Yosipovitch G, Legat FJ, et al. Trial of nemolizumab in moderate-to-severe prurigo nodularis. N Engl J Med. 2020;382(8):706–716. doi:10.1056/NEJMoa1908316
  • Zhang J, Fang H, Wang R, Dang E, Jiang M, Wang G. Effect of calcipotriol on IFN-γ-induced keratin 17 expression in immortalized human epidermal keratinocyte cells. Med Sci Monit. 2017;23:6049–6056. doi:10.12659/msm.904850
  • Shao S, Tsoi LC, Sarkar MK, et al. IFN-γ enhances cell-mediated cytotoxicity against keratinocytes via JAK2/STAT1 in lichen planus. Sci Transl Med. 2019;11(511):eaav7561. doi:10.1126/scitranslmed.aav7561
  • Linskey KR, Gimbel DC, Zukerberg LR, Duncan LM, Sadow PM, Nazarian RM. BerEp4, cytokeratin 14, and cytokeratin 17 immunohistochemical staining aid in differentiation of basaloid squamous cell carcinoma from basal cell carcinoma with squamous metaplasia. Arch Pathol Lab Med. 2013;137(11):1591–1598. doi:10.5858/arpa.2012-0424-OA
  • Lan YJ, Chen H, Chen JQ, Lei QH, Zheng M, Shao ZR. Immunolocalization of vimentin, keratin 17, Ki-67, involucrin, β-catenin and E-cadherin in cutaneous squamous cell carcinoma. Pathol Oncol Res. 2014;20(2):263–266. doi:10.1007/s12253-013-9690-5
  • Fernandez-Flores A. Cytokeratin 17 immunoexpression in actinic keratosis (bowenoid and nonbowenoid) and in Bowen disease. Ann Diagn Pathol. 2016;20:1–6. doi:10.1016/j.anndiagpath.2015.11.001
  • Babu S, Mockler DC, Roa-Peña L, et al. Keratin 17 is a sensitive and specific biomarker of urothelial neoplasia. Mod Pathol. 2019;32(5):717–724. doi:10.1038/s41379-018-0177-5
  • Yang L, Fan X, Cui T, Dang E, Wang G. Nrf2 promotes keratinocyte proliferation in psoriasis through up-regulation of keratin 6, keratin 16, and keratin 17. J Investig Dermatol. 2017;137(10):2168–2176. doi:10.1016/j.jid.2017.05.015
  • Zhuang Y, Han C, Li B, et al. NB-UVB irradiation downregulates keratin-17 expression in keratinocytes by inhibiting the ERK1/2 and STAT3 signaling pathways. Arch Dermatol Res. 2018;310(2):147–156. doi:10.1007/s00403-018-1812-1
  • Depianto D, Kerns ML, Dlugosz AA, Coulombe PA. Keratin promotes epithelial proliferation and tumor growth by polarizing the immune response in skin. Nat Genet. 2010;42(10):910–914. doi:10.1038/ng.665